INTRODUCTION
Spinal cord injury is a serious trauma to the central nervous system, which presents with high incidence, disability and cost. It is a serious hazard to human health, and places a heavy burden on patients and their families. Spinal cord injury causes the loss of numerous spinal neurons, and there is a lack of neurogenesis to promote spinal repair. Maintaining cell survival, regenerating axons, positioning regenerated axons, and rebuilding synapses are the main difficulties for functional recovery after spinal injury [1] . Although various methods including surgery, medication and physical rehabilitation are performed for the treatment of spinal injury, there is not an ideal effective method to cure spinal injury. Tissue-engineered cell transplantation provides a new approach for treating spinal cord injury, which may repair or regenerate injured axons and recover partial spinal functions. Currently, bone marrow mesenchymal stem cells (BMMSCs), embryonic stem cells (ESCs), and umbilical cord blood stem cells are used for treating spinal cord injury. BMMSCs have a good differentiation capacity, and transplanted BMMSCs can partially repair neural functions [2] . Brazelton et al [3] found that exogenous BMMSCs differentiate into glial cells and neurons after transplantation into mouse brain, suggesting that BMMSC transplantation can be used for treating spinal cord injury. Sasaki et al [4] used BMMSC transplantation to treat spinal cord injury and found that BMMSCs can repair the myelin sheath of damaged spinal axons. Neural stem cells show special features due to isogenesis with cells in spinal areas [5] . Thus, BMMSC transplantation has been the study focus of an increasing number of researchers [6] [7] . Additionally, gene-modified neural stem cells have been applied in clinical studies that mainly focus on providing a suitable microenvironment for stem cells in damaged spinal cord [8] [9] . The mechanisms of cell transplantation, which promote neural regeneration in damaged spinal function include: (1) Providing necessary conditions for neuronal and axonal regeneration; (2) To substitute or generate new neurons to form new synapses; and (3) To guide axons for alignment in order in tissueengineered scaffolds to form new synapses. In damaged spinal cord, interneurons derived from stem cells provide a bridge to possibly reconnect the damaged spinal cord and recover spinal functions [10] [11] [12] [13] .
Zuk et al [14] isolated adipose-derived mesenchymal stem cells and found that they can be induced to differentiate into neuron-like cells. Furthermore, Safford et al [15] found that adipose-derived mesenchymal stem cells can be induced to differentiate into neurons and cells from other tissues.
DATA SOURCES AND METHODOLOGY

Data retrieval
In this study, we used bibliometric analyses to quantitatively and qualitatively investigate research trends in studies of stem cell transplantation for treating spinal cord injury. For this purpose, we employed the Web of Science, a research database of publications and citations that are selected and evaluated by the Institute for Scientific Information in Philadelphia, PA, USA, using the key words "bone marrow mesenchymal stem cells" "embryonic stem cells" "umbilical cord blood derived mesenchymal stem cells" "adipose derived mesenchymal stem cells" "cell transplantation" and "spinal cord injury". We limited the period of publication from 2002 to 2011 to compile a bibliography of all articles related to stem cell transplantation for treating spinal cord injury. We downloaded the data on March 25, 2012.
Inclusion criteria
The inclusion criteria were as follows: (1) Peer-reviewed articles on stem cell transplantation for treating spinal cord injury, which were published and indexed in the Web of Science, including original research articles, reviews, meeting abstracts, proceedings papers, book chapters, editorial material, and news items; (2) the year of publication was 2002-2011; and (3) the citation database was Science Citation Index-Expanded.
Exclusion criteria
We excluded articles that required manual searching or telephone access, documents that were not published in the public domain, and a number of corrected papers from the total number of articles analyzed.
The outcomes of all articles referring to stem cell transplantation for treating spinal cord injury were measured using the following criteria. The contribution analysis of different countries/territories for publications was based on journal articles in which the address and affiliation of at least one author were provided. The total number of articles analyzed by country and institute publications was 191. From Table 2 , it is clear that Japan published the most papers on BMMSC transplantation for treating spinal cord injury. Japan published 34 papers that accounted for 25.75% of the total, which was much higher than the number of publications by other countries. China ranked second with 33 papers that accounted for 25%. The USA published 27 papers and ranked third. Hokkaido University, Sun Yat-sen University and the Query formulation Number of publication ts=("bone marrow stem cell*" or "bone marrow mesenchymal stem cell*" or "bone mesenchymal stem cell*" or "bone marrow stromal cell*"or "BMSC" or "BMSCs" or "BMHSCs") and ts=("spinal cord injury" or "spinal injury" or "spinal transection" or "spinal cord transection") 191 ts=(("embryonic stem cell*" or "embryonic-like stem cell*" or "embryonic pluripotent stem cell*" or "ESCs" or "ELSC" or "EPSC") same ("spinal cord injury" or "spinal injury" or "spinal transection" or "spinal cord transection")) 236 ts=(("umbilical cord blood stem cell*" or "cord blood stem cell*" or "umbilical cord blood derived mesenchymal stem cell*" or "umbilical cord blood hematopoietic stem cell*" or "hematopoietic progenitor cell*" or "CB-SCs" or "UCB-MSCs" or "UCB-MSC") same ("spinal cord injury" or "spinal injury" or "spinal transection" or "spinal cord transection")) 21 ts=(("adipose derived stem cell*" or "adipose derived mesenchymal stem cell*" or "ADSCs" or "ADMSC" or "ADMSCs" or "adipose tissue-derived stromal cell*") same ("spinal cord injury" or "spinal injury" or "spinal transection" or "spinal cord transection")) (Table 3) Among the seven articles with more than 60 citations, the article "bone marrow stromal cells infused into the cerebrospinal fluid promote functional recovery of the injured rat spinal cord with reduced cavity formation", published in 2004, was cited 117 times, which was more times than any other article. (Table 4) Among the publications, 12 articles were supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan, and eight articles were supported by the National Natural Science Foundation of China.
Most funding support for BMMSC transplantation for treating spinal cord injury from 2002 to 2011
Journals that published on BMMSC transplantation for treating spinal cord injury from 2002 to 2011 (Table 5) In Table 5 , it is evident that most papers on BMMSC transplantation for treating spinal cord injury appeared in journals with a particular focus on neuroscience research. [16] Experimental Neurology
117
Migration and differentiation of nuclear fluorescencelabeled bone marrow stromal cells after transplantation into cerebral infarct and spinal cord injury in mice [17] Neuropathology
90
Recovery of function following grafting of human bone marrow-derived stromal cells into the injured spinal cord [18] Neurorehabilitation and Neural Repair
81
Transplantation of bone marrow stem cells as well as mobilization by granulocyte-colony stimulating factor promotes recovery after spinal cord injury in rats [19] Journal of Neurotrauma
79
Transplantation of bone marrow stromal cell-derived Schwann cells promotes axonal regeneration and functional recovery after complete transection of adult rat spinal cord [20] Journal of Neuropathology and Experimental Neurology
67
Functional recovery in chronic paraplegia after bone marrow stromal cells transplantation [21] Neuroreport 2004 63
Bone marrow stem cells and polymer hydrogels-two strategies for spinal cord injury repair [22] Cellular and Molecular Neurobiology 2006 60 Cell Transplantation published 11 papers that accounted for 5.76% of the total number of publications, which was followed by the Journal of Neurotrauma that published 10 papers and accounted for 5.24%. The contribution analysis of different countries/territories for publications was based on journal articles in which the address and affiliation of at least one author were provided. The total number of articles analyzed for country and institute publications was 191. The top 10 countries/territories and institutions were then ranked.
Annual publication output for ESC transplantation
In Table 6 , it is clear that the USA published the most papers on ESC transplantation for treating spinal cord injury, with 110 papers that accounted for 46.61% of the total, which was much higher than the number of papers published by other countries. Japan ranked second with 21 papers that accounted for 8.89%. Germany published 19 papers and ranked third.
Washington University, University of California, Irvine, and Keio University are the most prolific research institutes publishing on ESC transplantation for treating spinal cord injury. Among the top 10 research institutes publishing in this field, five are in the USA, and the other five are in Japan, Sweden, the UK, Germany and Canada. (Table 7) Among the publications, 13 articles were supported by the NIH, and three articles were supported by CONACYT and the National Institutes of Health. The other funding agencies supported less than 2 publications. (Table 8 ) Among the 10 articles with more than 70 citations, the article "Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury", published in 2005, was cited 394 times, which was greater than any other article. (Table 9) In Table 9 , it is evident that most papers on ESC transplantation for treating spinal cord injury appeared in journals such as Stem Cells, Cell Transplantation and PLoS One. (Tables  10 and 11 ) 
Most funding support for ESC transplantation for treating spinal cord injury from 2002 to 2011
Most cited articles on ESC transplantation for treating spinal cord injury from 2002 to 2011
Journals that published on ESC transplantation for treating spinal cord injury from 2002 to 2011
Highly cited papers on other sources of stem cells for transplantation to treat spinal cord injury
Journal of Neuroscience
394
Differentiation of embryonic stem cells to clinically relevant populations: Lessons from embryonic development [24] Cell 2008 372
Therapeutic interventions after spinal cord injury [25] Nature Reviews Neuroscience
176
Therapeutic potential of embryonic stem cells [26] Blood Reviews 2005 86
Experimental strategies to promote spinal cord regeneration -an integrative perspective [27] Progress in Neurobiology
Updates on stem cells and their applications in regenerative medicine [28] 
Journal of Tissue Engineering and Regenerative Medicine
78
Stem cell-based cell therapy in neurological diseases: a review [29] Journal of Neuroscience Research
74
Magnetic resonance tracking of implanted adult and embryonic stem cells in injured brain and spinal cord [30] Stem Cell Biology: Development and Plasticity
73
The differentiation of embryonic stem cells seeded on electrospun nanofibers into neural lineages [31] Biomaterials 2009 70 Plasticity and therapeutic potential of mesenchymal stem cells in the nervous system [33] Current Pharmaceutical Design
81
Axonal remyelination by cord blood stem cells after spinal cord injury [34] 
Journal of Neurotrauma
36
Cellular MRI and its role in stem cell therapy [35] Regenerative Medicine
31
Umbilical cord blood stem cell mediated downregulation of Fas improves functional recovery of rats after spinal cord injury [36] Neurochemical Research
26
Transplantation of canine umbilical cord blood-derived mesenchymal stem cells in experimentally induced spinal cord injured dogs [37] Journal of Veterinary Science
23
Cord blood stem cells: A review of potential neurological applications [38] Stem Cell Reviews
The potential of cord blood stem cells for use in regenerative medicine [39] Expert Opinion on Biological Therapy 
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